Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HumanOptics AG

www.humanoptics.com

Latest From HumanOptics AG

Global Device Approvals, Weekly Snapshot: May 28-June 3, 2018

A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker.

Approvals Innovation

NuLens Ltd.

Today, most of the accommodating and multifocal IOLs that address presbyopia share one thing in common: they are placed, as are the standard lenses used in routine cataract procedures, inside the capsular bag, a thin membrane surrounding the eye's natural lens. It's becoming increasingly apparent that over time, the capsular bag undergoes changes that compromise visual results. NuLens came up with the idea of not using the capsular bag as the housing for the accommodating lens.
Medical Device

Visiogen Inc.

Visiogen Inc.'s Synchrony accommodating intraocular lens has dual optics, meaning that the ciliary muscles don't have to move it as much as other IOLs. The result, the company claims, is more accommodative power that translates into better vision at all distances. Like all IOL makers, Visiogen's point-of-entry will be cataract surgery, but it is eyeing the large presbyopia market.

Presbyopia at Arm's Length

VCs have funded at least a dozen start-ups working in presbyopia, including C&C Vision, whose founder Stuart Cumming has been quietly working on an accomodating intraocular lens for more than ten years. With the FDA's Ophthalmic Devices Panel unanimously recommending premarket approval of C&C Vision's CrystaLens accommodating intraocular lens for cataract patients, his firm is very close to being able to reap a first-mover advantage in this new market.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • HumanOptics AG
  • Senior Management
  • Karl Klamann, CEO
  • Contact Info
  • HumanOptics AG
    Phone: (49) 9131 50665 86
    Spardorfer Str. 150
    91054 Erlangen,
    Germany
UsernamePublicRestriction

Register